New On Robinhood

Praxis Precision Medicines

$57.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.31 (-3.86%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell PRAX and other stocks, options, and ETFs commission-free!

About PRAX

Praxis Precision Medicines, Inc. Common Stock, also called Praxis Precision Medicines, is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA. The listed name for PRAX is Praxis Precision Medicines, Inc. Common Stock.

CEO
Marcio Souza
Employees
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
2.10B
Price-Earnings Ratio
Dividend Yield
Average Volume
250.83K
High Today
$59.48
Low Today
$56.01
Open Price
$59.25
Volume
201.30K
52 Week High
$60.79
52 Week Low
$23.90

Collections

PRAX Earnings

-$12.10
-$8.07
-$4.03
$0.00
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 5, Pre-Market

You May Also Like

LX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure